S-adenosyl methionine improves early viral responses and interferon-stimulated gene induction in hepatitis C nonresponders.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/20854821
Conclusion of this study
The addition of SAMe to peginterferon and ribavirin improves the early viral kinetics and increases ISG induction in nonresponders to previous therapy. SAMe might be a useful adjunct to peginterferon-based therapies in chronic HCV infection.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study